Pollak M - Search Results

1

Metformin attenuates the stimulatory effect of a high-energy diet on in vivo LLC1 carcinoma growth.

Algire C, Zakikhani M, Blouin MJ, Shuai JH, Pollak M. Algire C, et al. Among authors: pollak m. Endocr Relat Cancer. 2008 Sep;15(3):833-9. doi: 10.1677/ERC-08-0038. Epub 2008 May 9. Endocr Relat Cancer. 2008. PMID: 18469156

2

Castration-induced apoptosis of androgen-dependent shionogi carcinoma is associated with increased expression of genes encoding insulin-like growth factor-binding proteins.

Nickerson T, Miyake H, Gleave ME, Pollak M. Nickerson T, et al. Among authors: pollak m. Cancer Res. 1999 Jul 15;59(14):3392-5. Cancer Res. 1999. PMID: 10416600

3

Silibinin up-regulates insulin-like growth factor-binding protein 3 expression and inhibits proliferation of androgen-independent prostate cancer cells.

Zi X, Zhang J, Agarwal R, Pollak M. Zi X, et al. Among authors: pollak m. Cancer Res. 2000 Oct 15;60(20):5617-20. Cancer Res. 2000. PMID: 11059749

4

Reduced mammary gland carcinogenesis in transgenic mice expressing a growth hormone antagonist.

Pollak M, Blouin MJ, Zhang JC, Kopchick JJ. Pollak M, et al. Br J Cancer. 2001 Aug 3;85(3):428-30. doi: 10.1054/bjoc.2001.1895. Br J Cancer. 2001. PMID: 11487276 Free PMC article.

5

Growth inhibition of breast epithelial cells by celecoxib is associated with upregulation of insulin-like growth factor binding protein-3 expression.

Levitt RJ, Buckley J, Blouin MJ, Schaub B, Triche TJ, Pollak M. Levitt RJ, et al. Among authors: pollak m. Biochem Biophys Res Commun. 2004 Apr 2;316(2):421-8. doi: 10.1016/j.bbrc.2004.02.062. Biochem Biophys Res Commun. 2004. PMID: 15020235

6

Insulin-like growth factors and neoplasia.

Pollak MN. Pollak MN. Novartis Found Symp. 2004;262:84-98; discussion 98-107, 265-8. Novartis Found Symp. 2004. PMID: 15562824 Review.

7

A germ line mutation that delays prostate cancer progression and prolongs survival in a murine prostate cancer model.

Majeed N, Blouin MJ, Kaplan-Lefko PJ, Barry-Shaw J, Greenberg NM, Gaudreau P, Bismar TA, Pollak M. Majeed N, et al. Among authors: pollak m. Oncogene. 2005 Jul 7;24(29):4736-40. doi: 10.1038/sj.onc.1208572. Oncogene. 2005. PMID: 15870705

8

Inhibition of insulin-like growth factor-1 receptor signaling enhances growth-inhibitory and proapoptotic effects of gefitinib (Iressa) in human breast cancer cells.

Camirand A, Zakikhani M, Young F, Pollak M. Camirand A, et al. Among authors: pollak m. Breast Cancer Res. 2005;7(4):R570-9. doi: 10.1186/bcr1028. Epub 2005 Apr 12. Breast Cancer Res. 2005. PMID: 15987464 Free PMC article.

9

Insulin-like growth factor receptor I targeting in epithelial ovarian cancer.

Gotlieb WH, Bruchim I, Gu J, Shi Y, Camirand A, Blouin MJ, Zhao Y, Pollak MN. Gotlieb WH, et al. Gynecol Oncol. 2006 Feb;100(2):389-96. doi: 10.1016/j.ygyno.2005.09.048. Epub 2005 Nov 21. Gynecol Oncol. 2006. PMID: 16300820

10

Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells.

Zakikhani M, Dowling R, Fantus IG, Sonenberg N, Pollak M. Zakikhani M, et al. Among authors: pollak m. Cancer Res. 2006 Nov 1;66(21):10269-73. doi: 10.1158/0008-5472.CAN-06-1500. Epub 2006 Oct 23. Cancer Res. 2006. PMID: 17062558

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

865 results

Search Page

Filters